NCT07076459View on ClinicalTrials.gov

A Comparative Pharmacokinetic Study of Single-Dose Administration of HR091506 Tablets From Different Batches in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 10, 2025

Primary Completion Date

August 18, 2025

Study Completion Date

August 18, 2025

Conditions
Health Volunteer
Interventions
DRUG

HR091506 tablet

In each period under fed conditions, subjects received oral administration of either HR091506 tablet（T1）, HR091506 tablet（T2）, or HR091506 tablet（R）.

Trial Locations (1)

061000

Cangzhou Central Hospital, Cangzhou

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY